Breaking Finance News

Boston Scientific Up After Strong Earnings Release

Shares of Boston Scientific (NYSE: BSX) are up about 1 percent after the company release its fiscal Q4 earnings this morning.

The company reported adjusted Q4 EPS of $0.21 versus the estimated $0.09, beating by $0.12. EPS were up 110% year over year. Revenue came in at $1.84 billion versus the estimated $1.73 billion. Sales were up 6% year over year.

Guidance calls for Q1 EPS $0.16-0.18 vs the $0.12 estimate. The company sees sales of $1.75 billion-1.80 billion vs the $1.80 billion estimate.

For the year, Boston Scientific sees EPS of $0.47-$0.52 per share vs the $0.52 estimate.

“I am pleased with our results for the quarter and our return to operational revenue growth for the full year 2013,” stated Mike Mahoney, president and chief executive officer, Boston Scientific Corporation.  “This marks our third consecutive quarter of accelerated operational revenue growth and we look forward to continued improvement of our annual sales and earnings performance in 2014.”

Disclosure: At the time of this writing, Tim Parker had no position in the company mentioned.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.